Rocket Lab jumps as Mynaric acquisition closes and investors look to May earnings
Rocket Lab shares rose after the company finalized its $155.3 million acquisition of Mynaric on April 14, 2026, adding laser optical communications terminals to its space-systems portfolio. Investors are also positioning ahead of Rocket Lab’s Q1 2026 earnings report scheduled for May 7, 2026.
1. What’s moving the stock today
Rocket Lab (RKLB) is trading higher as the market digests the closing of its Mynaric acquisition, a deal that expands Rocket Lab into laser optical communications terminals used for space and defense networking. Rocket Lab said it completed the transaction on April 14, 2026 for an aggregate consideration value of $155.3 million, consisting of a nominal cash payment plus 2,277,002 shares of common stock, giving investors a concrete “deal closed” catalyst to underwrite rather than a pending, regulatory-risk headline. (rocketlabcorp.com)
2. Why the Mynaric asset matters
Laser inter-satellite links are viewed as a critical enabling technology for resilient, high-throughput constellations, and Rocket Lab is positioning the Mynaric product line as a way to deepen vertical integration in space systems. Rocket Lab highlighted that Mynaric is a supplier tied into the same customer ecosystem Rocket Lab targets—spanning commercial constellation operators, prime contractors, and government agencies—supporting a narrative of higher-value payload and satellite-content capture over time. (rocketlabcorp.com)
3. The next catalyst on the calendar
Traders are also looking ahead to the next near-term corporate event: Rocket Lab said it will report first-quarter 2026 results after the market close on Thursday, May 7, 2026, with a conference call at 5:00 p.m. ET. With the stock already reacting to recent strategic news, the May report becomes the next focal point for updates on integration, demand, and the company’s broader space-systems momentum. (investors.rocketlabcorp.com)
4. What investors will watch next
After the acquisition close, investors will be watching for details on production scaling, customer pull-through, and how Mynaric fits into Rocket Lab’s roadmap for serving defense and commercial constellation programs. Attention will also stay on execution and cadence, as Rocket Lab’s prior updates have emphasized growing backlog and major program wins as the company broadens beyond launch into a more diversified space-systems prime. (investors.rocketlabcorp.com)